Dov Elefant - 07 Aug 2026 Form 4 Insider Report for FEMASYS INC (FEMY)

Reporting relationship: Chief Financial Officer
Issuer ticker: FEMY
Reported as of: 07 Aug 2026
Net transaction value: +$50,000
SEC form: 4
Accepted by SEC: 11 Aug 2026, 20:37:01 UTC
Prior SEC filing: 27 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Kathy Lee-Sepsick, Attorney-in-fact

Key filing fact

Dov Elefant filed Form 4 for FEMASYS INC (FEMY) on 11 Aug 2026.

Key facts

This page summarizes Dov Elefant's Form 4 filing for FEMASYS INC (FEMY).
3 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 11 Aug 2026, 20:37.

Change

Previous filing in this sequence was filed on 27 Mar 2026.
Current net transaction value: +$50,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001326487 Primary reporting owner

Elefant Dov

Relationship: Chief Financial Officer
Address: C/O FEMASYS INC., 3950 JOHNS CREEK COURT, SUITE 100, SUWANEE
Signature: /s/ Kathy Lee-Sepsick, Attorney-in-fact
Signature date: 11 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

FEMY transaction

Common Stock

Purchase

Transaction value: $50,000
Shares: +15,625
Change %
Price: $3.20
Shares after: 15,625
Date: 07 Aug 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

FEMY transaction Derivative

Common Stock Purchase Warrant

Award

Transaction value
Shares: +15,625
Change %
Price
Shares after: 15,625
Date: 07 Aug 2026
Ownership: Direct
Underlying class: Common stock, par value $0.001 per share
Underlying amount: 15,625
Exercise price: $2.95
Footnotes: F2, F3, F4

FEMY transaction Derivative

Common Stock Purchase Warrant (Milestone)

Award

Transaction value
Shares: +15,625
Change %
Price
Shares after: 15,625
Date: 07 Aug 2026
Ownership: Direct
Underlying class: Common stock, par value $0.001 per share
Underlying amount: 15,625
Exercise price: $2.95
Footnotes: F2, F3, F4, F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

The purchase price paid by the reporting person for the Shares was $3.20 per share pursuant to the Securities Purchase Agreement, dated as of August 7, 2026, by and among Femasys Inc. and the purchasers party thereto.

Footnote F2

Holder may, at its option, exercise the Common Warrant, subject to the terms and conditions thereof, at an exercise price of $2.95 per share of Common Stock. The exercise price is subject to adjustment in accordance with the terms of the Common Warrant and will be subject to standard adjustments in the event of any stock split, stock dividend, stock combination, recapitalization or other similar transactions.

Footnote F3

The Holder's ability to exercise the subject Warrant for shares of Common Stock is subject to certain limitations, in accordance with rules of the Nasdaq Capital Market.

Footnote F4

The reported securities were purchased by the reporting person for an aggregate amount of $50,000.

Footnote F5

The Common Warrant (Milestone) is exercisable only from and after the Milestone Date, being the first date on or after August 10, 2027 on which both (i) the Company has achieved U.S. revenue of $1,500,000 for any fiscal quarter, as reported in a Form 10-Q or Form 10-K, and (ii) the volume-weighted average price of the Common Stock has satisfied certain price conditions specified in the warrant. The warrant expires on the earlier of (i) three years after the effective date of a registration statement registering the resale of the Warrant Shares and (ii) 45 days after the Company delivers notice that the Milestone Date has occurred. As of the date of this report, neither the Milestone Date nor the expiration date is determinable.